The expression of inflammatory genes is upregulated in peripheral blood of patients with type 1 diabetes

Diabetes Care

Volumn 36, Issue 9, 2013, Pages 2794-2802

  Jin, Yulan ^a   Sharma, Ashok ^a   Carey, Colleen ^a   Hopkins, Diane ^a   Wang, Xiaoxiao ^a   Robertson, David G ^b   Bode, Bruce ^b   Anderson, Stephen W ^c   Reed, John Chip ^d   Steed, R Dennis ^d   Steed, Leigh ^a   She, Jin Xiong ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b ATLANTA DIABETES ASSOCIATES   (United States)

^c Pediatric Endocrine Associates   (United States)

^d Southeastern Endocrine and Diabetes   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN A; CALGRANULIN B; CD74 ANTIGEN; INTERLEUKIN 12P35; SMAD7 PROTEIN;

ANTIGEN PRESENTATION; ARTICLE; BONE MARROW CELL; CD74 GENE; CONTROLLED STUDY; FEMALE; GENE; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GNLY GENE; HUMAN; HUMAN CELL; IL12A GENE; IMMUNOREGULATION; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MNDA GENE; PERIPHERAL BLOOD MONONUCLEAR CELL; PSMA4 GENE; PSMB3 GENE; REAL TIME POLYMERASE CHAIN REACTION; S100A8 GENE; S100A9 GENE; SELL GENE; SMAD7 GENE; TGFB1 GENE; UPREGULATION; VALIDATION PROCESS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CALGRANULIN A; CALGRANULIN B; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; INTERLEUKIN-12 SUBUNIT P35; L-SELECTIN; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION; YOUNG ADULT;

EID: 84891776462     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc12-1986     Document Type: Article

References (38)

1. Britten AC, Mijovic CH, Barnett AH, Kelly MA. Differential expression of HLA-DQ alleles in peripheral blood mononuclear cells: alleles associated with susceptibility to and protection from autoimmune type 1 diabetes. Int J Immunogenet 2009;36: 47-57
2. Collins CD, Purohit S, Podolsky RH, et al. The application of genomic and proteomic technologies in predictive, preventive and personalized medicine. Vascul Pharmacol 2006;45: 258-267
3. Kaizer EC, Glaser CL, Chaussabel D, Banchereau J, Pascual V, White PC. Gene expression in peripheral blood mononuclear cells from children with diabetes. J Clin Endocrinol Metab 2007;92: 3705-3711
4. Padmos RC, Schloot NC, Beyan H, et al.; LADA Consortium. Distinct monocyte gene-expression profiles in autoimmune diabetes. Diabetes 2008;57: 2768-2773
5. Rassi DM, Junta CM, Fachin AL, et al. Gene expression profiles stratified according to type 1 diabetes mellitus susceptibility regions. Ann N Y Acad Sci 2008;1150: 282-289
6. Chervoneva I, Li Y, Schulz S, et al. Selection of optimal reference genes for normalization in quantitative RT-PCR. BMC Bioinformatics 2010;11:253
7. Stamova BS, Apperson M, Walker WL, et al. Identification and validation of suitable endogenous reference genes for gene expression studies in human peripheral blood. BMC Med Genomics 2009;2:49
8. Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of realtime quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002;3: RESEARCH0034
9. Sekhon JS. Multivariate and propensity score matching software with automated balance optimization: the matching package for R. J Stat Softw 2011;42: 1-52
10. Devaraj S, Cheung AT, Jialal I, et al. Evidence of increased inflammation and microcirculatory abnormalities in patients with type 1 diabetes and their role in microvascular complications. Diabetes 2007; 56: 2790-2796
11. Treszl A, Szereday L, Doria A, King GL, Orban T. Elevated C-reactive protein levels do not correspond to autoimmunity in type 1 diabetes. Diabetes Care 2004;27: 2769-2770
12. Zhi W, Sharma A, Purohit S, et al. Discovery and validation of serum protein changes in type 1 diabetes patients using high throughput two dimensional liquid chromatography-mass spectrometry and immunoassays. Mol Cell Proteomics 2011;10:M111, 012203
13. Abbasi F, Amiri P, Sayahpour FA, et al. TGF-b and IL-23 gene expression in unstimulated PBMCs of patients with diabetes. Endocrine 2012;41: 430-434
14. Han D, Leyva CA, Matheson D, et al. Immune profiling by multiple gene expression analysis in patients at-risk and with type 1 diabetes. Clin Immunol 2011;139: 290-301
15. Prud'homme GJ, Piccirillo CA. The inhibitory effects of transforming growth factor-beta-1 (TGF-beta1) in autoimmune diseases. J Autoimmun 2000;14: 23-42
16. Gorelik L, Flavell RA. Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 2000;12: 171-181
17. Gorelik L, Constant S, Flavell RA. Mechanism of transforming growth factor betainduced inhibition of T helper type 1 differentiation. J Exp Med 2002;195: 1499-1505
18. Apostolou I, Verginis P, Kretschmer K, Polansky J, Hühn J, von Boehmer H. Peripherally induced Treg: mode, stability, and role in specific tolerance. J Clin Immunol 2008;28: 619-624
19. Dardalhon V, Awasthi A, Kwon H, et al. IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Nat Immunol 2008;9: 1347-1355
20. Liu Y, Zhang P, Li J, Kulkarni AB, Perruche S, Chen W. A critical function for TGF-beta signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells. Nat Immunol 2008;9: 632-640
21. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006; 24: 179-189
22. Yan X, Liu Z, Chen Y. Regulation of TGFbeta signaling by Smad7. Acta Biochim Biophys Sin (Shanghai) 2009;41: 263-272
23. Fraser D. SMAD7: at the interface of TGFbeta and proinflammatory signaling. Perit Dial Int 2007;27: 523-525
24. Wolf G, Ziyadeh FN. Cellular and molecular mechanisms of proteinuria in diabetic nephropathy. Nephron Physiol 2007;106:p26-p31
25. Marcovecchio ML, Tossavainen PH, Dunger DB. Prevention and treatment of microvascular disease in childhood type 1 diabetes. Br Med Bull 2010;94: 145-164
26. Cheung AT, Tomic MM, Chen PC, Miguelino E, Li CS, Devaraj S. Correlation of microvascular abnormalities and endothelial dysfunction in Type-1 Diabetes Mellitus (T1DM): a real-time intravital microscopy study. Clin Hemorheol Microcirc 2009;42: 285-295
27. Bouma G, Coppens JM, Lam-Tse WK, et al. An increased MRP8/14 expression and adhesion, but a decreased migration towards proinflammatory chemokines of type 1 diabetes monocytes. Clin Exp Immunol 2005;141: 509-517
28. Burkhardt K, Schwarz S, Pan C, et al. Myeloid-related protein 8/14 complex describes microcirculatory alterations in patients with type 2 diabetes and nephropathy. Cardiovasc Diabetol 2009;8: 10
29. Bouma G, Lam-Tse WK, Wierenga-Wolf AF, Drexhage HA, Versnel MA. Increased serum levels of MRP-8/14 in type 1 diabetes induce an increased expression of CD11b and an enhanced adhesion of circulating monocytes to fibronectin. Diabetes 2004;53: 1979-1986
30. Viemann D, Strey A, Janning A, et al. Myeloid-related proteins 8 and 14 induce a specific inflammatory response in human microvascular endothelial cells. Blood 2005;105: 2955-2962
31. Ehlermann P, Eggers K, Bierhaus A, et al. Increased proinflammatory endothelial response to S100A8/A9 after preactivation through advanced glycation end products. Cardiovasc Diabetol 2006;5:6
32. Fotouhi-Ardakani N, Kebir DE, Pierre- Charles N, et al. Role for myeloid nuclear differentiation antigen in the regulation of neutrophil apoptosis during sepsis. Am J Respir Crit Care Med 2010;182: 341-350
33. Yang XD, Karin N, Tisch R, Steinman L, McDevitt HO. Inhibition of insulitis and prevention of diabetes in nonobese diabetic mice by blocking L-selectin and very late antigen 4 adhesion receptors. Proc Natl Acad Sci USA 1993;90: 10494-10498
34. Lepault F, Gagnerault MC, Faveeuw C, Bazin H, Boitard C. Lack of L-selectin expression by cells transferring diabetes in NOD mice: insights into the mechanisms involved in diabetes prevention by Mel-14 antibody treatment. Eur J Immunol 1995; 25: 1502-1507
35. Friedline RH, Wong CP, Steeber DA, Tedder TF, Tisch R. L-selectin is not required for T cell-mediated autoimmune diabetes. J Immunol 2002;168: 2659-2666
36. Pawłowski P, Urban M, Peczỹnska J. Could the expression of L-selectin be an early marker of arterial hypertension and microangiopathy in the course of type 1 diabetes mellitus in juvenile patients?. Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw 2005;11:147-152 [in Polish]
37. Kretowski A, Gillespie KM, Bingley PJ, Kinalska I. Soluble L-selectin levels in type I diabetes mellitus: a surrogate marker for disease activity? Immunology 2000;99: 320-325
38. Kordonouri O, Bührer C. Circulating L-selectin concentrations in children with recent-onset IDDM. J Pediatr Endocrinol Metab 2000;13: 85-89